top of page
gradientForSurfBreak.png

Item List

Yahoo
Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of the Rare Patient Network expanding Invitae's Ciitizen platform to all patients with pediatric epilepsy and/or developmental delay with plans to include other conditions in the coming months. By engaging with a broader community, Invitae, a leader in the rare pediatric neurodevelopmental field, aims to create value for significantly more patients with rare diseases.

Recent Posts

Portfolio Company

Carlsmed.png

Selfii Announces TripleBlind Exchange, a First-of-its-Kind Marketplace Providing ...

Businesswire

Portfolio Company

Carlsmed.png

Atropos Health and xCures Advance Artificial Intelligence (AI) to Improve Clinic ...

Businesswire

Portfolio Company

Carlsmed.png

DeepScribe and Pearl Health Announce Partnership to Bring Ambient AI Documentati ...

StreetInsider

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page